We are focused on bringing our cell therapies to patients in need.

Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility.

The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

Our Passionate Mission


To develop new therapies that are
based on breakthrough science


To bring hope to patients with
serious or life-threatening diseases


To treat life-threatening diseases,
bringing societal benefit


To realize unique treatment
opportunities for patients and value for investors

Our core values are Integrity, Courage and Ingenuity

Integrity means that we are open, honest, and genuine. Courage means that we are entrepreneurial, take calculated risks, and strive to reach beyond the boundaries of accepted theories. Ingenuity means that we discover, invent, and use our discoveries for the benefit of the patients.

Meet Our People